Who is sponsoring NCT05639478?

NCT05639478 is sponsored by University of Sao Paulo General Hospital.

What drugs are being tested in NCT05639478?

Interventions in NCT05639478: Foot-related exercises.

What condition does NCT05639478 study?

NCT05639478 studies Diabetes; Neuropathy, Polyneuropathy (Manifestation).

Is NCT05639478 still recruiting?

NCT05639478 is currently recruiting now. Last updated 24 February 2026.

Last reviewed 2026-02-24 · How we verify

NCT05639478: FOCAIN

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

FOot CAre and Exercises ImplementatioN for People With Diabetes in Primary Care

Recruiting now NA Last updated 24 February 2026

What this trial tests

NA trial testing Foot-related exercises in Diabetes; Neuropathy, Polyneuropathy (Manifestation) in 356 participants. Currently enrolling.

Timeline

1 March 2023

Primary endpoint
30 June 2026

31 August 2026

Quick facts

Lead sponsor	University of Sao Paulo General Hospital
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	356
Start date	1 March 2023
Primary completion	30 June 2026
Estimated completion	31 August 2026
Sites	1 location across Brazil

Drugs / interventions tested

Foot-related exercises

Conditions studied

Diabetes; Neuropathy, Polyneuropathy (Manifestation) — all drugs for Diabetes; Neuropathy, Polyneuropathy (Manifestation) →

Sponsor

University of Sao Paulo General Hospital

Who can join

18 and older, any sex, with Diabetes; Neuropathy, Polyneuropathy (Manifestation). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main objective of this type 2 hybrid implementation effectiveness trial is to implement a contextually appropriate preventive intervention for 12 weeks face to face group foot and ankle exercises for people with diabetic foot in the primary care of the city of Limeira/SP, through the training of Primary Care workers. The study will monitor the implementation itself and the clinical outcomes: clinical and functional status and quality of life.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Implementing a contextually appropriate foot-ankle exercise programme in primary care for the prevention of modifiable risk factors for ulcers in people with diabetes: protocol for a hybrid type 2 study.
Rodrigues CB, Soares PNC, Schmitt ACB, Sacco ICN. · · 2024 · cited 2× · PMID 38316587 · DOI 10.1136/bmjopen-2023-078958
From evidence to action: contextual determinants for the pre-implementation of a foot-ankle exercise program for diabetes in primary care.
Soares PNC, Sacco ICN, Rodrigues CB, Santos GS, et al · · 2026 · PMID 41527130 · DOI 10.1186/s12913-025-13971-4

Verify or expand the search:

Other University of Sao Paulo General Hospital trials

Trials by the same sponsor.

NCT07275580 — Antibiotic Prophylaxis After Simple Tooth Extraction in Immunosuppressed Patients With Autoimmune Rheumatic Diseases · Phase 4 · not yet recruiting
NCT07478094 — Longitudinal Outcomes of Patients With Group 3 Pulmonary Hypertension Treated With Iloprost · not yet recruiting
NCT07341386 — Prevention of Recurrence of Herpes Simplex in Autoimmune Rheumatic Diseases · Phase 4 · not yet recruiting
NCT07242092 — Influence of Methotrexate Discontinuation on Immunogenicity After PCV-20 Vaccine in Patients ARDs · Phase 4 · not yet recruiting
NCT07484152 — Motor and Non-Motor Effects of Low-Intensity Focused Ultrasound (LIFU) as a Neuromodulation Tool in Essential Tremor · Phase 1, PHASE2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05639478 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Sao Paulo General Hospital
Last refreshed: 24 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05639478.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing